Cartesian Therapeutics, Inc. Contract with Customer, Liability, Noncurrent
Cartesian Therapeutics, Inc. (RNAC) had Contract with Customer, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2025-03-13
- 2024-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-09-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-06-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-03-31: Contract with Customer, Liability, Noncurrent $0.00.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.54M 10-K · filed 2025-03-13 |
| 2023-09-30 | $3.98M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.86M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $5.52M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 |
| 2022-09-30 | $5.44M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.11M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $10.42M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $11.42M 10-K · filed 2023-03-02 |
| 2021-09-30 | $20.06M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $24.74M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $32.30M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $38.75M 10-K · filed 2022-03-10 |
| 2020-09-30 | $51.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.41M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.66M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.68M 10-K · filed 2021-03-12 |
| 2019-09-30 | $14.98M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $14.98M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $13.82M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $13.82M 10-K · filed 2020-03-12 |
| 2018-09-30 | $13.82M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $12.87M 10-Q · filed 2018-08-08 |
| 2018-01-01 | $14.09M 10-K · filed 2019-03-15 |
| 2017-12-31 | $15.92M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |